Clinical Trial Update: A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-valvular Atrial Fibrillation [Phase 2]

View source ↗

Summary

A Phase 2 study assessing the safety of a potential new drug versus warfarin for non-valvular atrial fibrillation, completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Thromboembolism

Snippet

Sponsor: Daiichi Sankyo | Conditions: Atrial Fibrillation, Thromboembolism | Phase 2 | Status: COMPLETED | Results posted: 2015-03-13